Lipocine reports plans to conduct public offering of its common stock

Bookrunners Canaccord Genuity and Ladenburg Thalmann assist with sale

By Devika Patel

Knoxville, Tenn., April 23 – Lipocine Inc. said it sell common stock to the public with a 30-day greenshoe.

Canaccord Genuity Inc. and Ladenburg Thalmann are the bookrunners.

Proceeds will be used for general corporate purposes, including working capital and capital expenditures.

The specialty pharmaceutical company is based in Salt Lake City.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.